European urology oncology

01 16 October 2026

DOI 10.1016/j.euo.2026.09.019

Re: Alfonso Santangelo, Wooju Jeong, Caro Silvani, et al. Long-term Oncological Outcomes of Retzius-sparing Versus Anterior Robot-assisted Radical Prostatectomy: Post Hoc Analysis of a Randomized Cohort. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2026.07.012

Open DOI

Denis Seguier, Arnauld Villers, Jonathan Olivier

02 16 October 2026

DOI 10.1016/j.euo.2026.10.002

Prostate Cancer Incidence and Disease Characteristics in Transgender Women Receiving Gender-affirming Hormone Therapy: A Systematic Review with Meta-analysis

Open DOI

Kunind Oberoi, Isabella Trevaskis, Sadia Hassan et al.

03 15 October 2026

DOI 10.1016/j.euo.2026.09.015

Machine Learning Models Combining [68Ga]Ga-PSMA-11 PET Radiomics and Clinical Features to Predict Overall Survival for Metastatic Castration-resistant Prostate Cancer Treated with [177Lu]Lu-PSMA Radioligand Therapy

Open DOI

Lucas Edouard, Léa Papillon, Loïc Ferrer et al.

04 15 October 2026

DOI 10.1016/j.euo.2026.09.020

Re: Luc Delobel, Arnauld Villers, Denis Seguier, et al. Long-term Prediction of Metastatic Recurrence in Patients Candidate to Radical Prostatectomy Using MRI and Targeted Biopsy: Insights into Tumor Zonal Origin. Eur Urol Oncol. In press. http://dx.doi.org/10.1016/j.euo.2026.08.009

Open DOI

Mohamad Watfa, Jane K. Nguyen, Zeyad R. Schwen

05 6 October 2026

DOI 10.1016/j.euo.2026.09.014

Metastasis-free Survival in High-risk Prostate Cancer: A Valid Surrogate, but Is it Transportable Across Strategies of Unequal Systemic Exposure?

Open DOI

Michael Baboudjian, Alessandro Uleri, Giuseppe Fallara et al.

06 5 October 2026

DOI 10.1016/j.euo.2026.08.014

Efficacy and Safety of Olaparib plus Abiraterone Versus Placebo plus Abiraterone in the Non-BRCA Mutation Subgroup of Patients with Metastatic Castration-resistant Prostate Cancer in the PROpel Trial

Open DOI

Niven Mehra, Noel W. Clarke, Andrew J. Armstrong et al.

07 1 October 2026

DOI 10.1016/j.euo.2026.09.007

Natural History After Likely Cure Versus Recurrence After Prostate Radiotherapy (RAPTOR)

Open DOI

Soumyajit Roy, Tahmineh Romero, Mack Roach et al.

08 29 September 2026

DOI 10.1016/j.euo.2026.09.010

Rethinking the 3-cm Rule: Toward Biology-guided Management of Sporadic Bilateral Multifocal Papillary Renal Cell Carcinoma

Open DOI

Selcuk Erdem, Chiara Re, Umberto Capitanio

09 26 September 2026

DOI 10.1016/j.euo.2026.08.012

Reply to Roberto M. Scarpa’s Letter to the Editor re: Paolo Gontero, Richard Perry, Daisy Bridge, et al. Unmet Treatment Need and Challenges Associated with Comparative Evidence Generation in BCG-unresponsive Non–muscle-invasive Bladder Cancer: An Expert Consensus. Eur Urol Oncol 2026;9(3):652–9

Open DOI

Paolo Gontero, Marek Babjuk

10 26 September 2026

DOI 10.1016/j.euo.2026.09.008

Adjuvant Pembrolizumab in Clear Cell Renal Cell Carcinoma: Eligibility Is Only the Beginning

Open DOI

Francesco Rossi, Massimiliano Depalma, Bernardo Rocco et al.